Karen Jauregui
Karen Jauregui has over 25 years of experience in drug development including regulatory strategy, quality assurance, clinical operations, and project management. Karen joined Imbria Pharmaceuticals as the Head of Regulatory Affairs and Quality in April 2020 and was promoted to Senior VP of RA, QA and CMC in June 2021.
Prior to joining Imbria, Karen was the Vice President of Regulatory Affairs and Quality Assurance at resTORbio Inc., a company focused on the development of drugs for the treatment of diseases related to aging.
Previously, Karen was the Vice President of Regulatory Affairs at Akebia Inc, where she was responsible for the Phase 3 global regulatory strategy to develop a treatment for renal anemia. Karen also worked at EMD Serono and Repligen Corporation where she held numerous positions of increasing responsibility in Clinical Operations and Regulatory Affairs. She has a BS in Biology and Medical Technology from the State University of New York at Plattsburgh.